摘要: <正> 已鉴定正式协议,SmithKline Beckman Corp.和 Beecham Group Plc 将合并为新的大型制药企业,称为 SmithKline Beecham。共有67亿美元销售额和5亿美元 R&D 预算额的该公司将成为继 Merck&Co.之后世界第二大制药企业。 关键词: 制药企业:5939, 合并:4424, 交易:3788, 正式协议:3525, 新公司:2226, ...
GlaxoSmithKline is a leading British pharmaceutical and biotechnology company formed by the merger of Glaxo Wellcome PLC and SmithKline Beecham PLC in 2000. The company has a long history of developing health-focused and innovative vaccines and medicines. Meet the GlaxoSmithKline PLC leaders and executiv...
Reports that SmithKline Beecham PLC exercised an option to co-develop and commercialize a wound-healing drug discovered by Human Genome Sciences Inc. Significance of the decision; Background on the drug, repifermin.EBSCO_bspWall Street Journal - Eastern Edition...
09/202781 Publication Date: 02/15/2000 Filing Date: 06/23/1999 Export Citation: Click for automatic bibliography generation Assignee: SmithKline Beecham plc (Brentford, GB) Primary Class: 514/307 Other Classes: 546/143, 546/146, 546/148 ...
摘要: 已鉴定正式协议,SmithKline Beckman Corp.和 Beecham Group Plc 将合并为新的大型制药企业,称为 SmithKline Beecham.共有67亿美元销售额和5亿美元 RD 预算额的该公司将成为继 MerckCo.之后世界第二大制药企业.关键词:Beecham SmithKline 大型制药企业 预算额 Merck 制药工业 生物技术 市场占有率 管理职位 ...
LONDON (CBS.MW) -- Glaxo Wellcome PLC said Monday it will buy SmithKline Beecham PLC for $76 billion in stock, creating the biggest pharmaceutical company in the world. The move is widely expected to speed global consolidation in the drug industry. Although the companies described the ...
and SmithKline Beecham Corporation, a corporation organized under the laws of the Commonwealth of Pennsylvania, United States of America, having a place of business at 709 Swedeland Road, King of Prussia, Pennsylvania, 19406 and SmithKline Beecham, plc, having a place of business at Great West ...
Reports on the proposed merger of Glaxo Wellcome PLC and SmithKline Beecham PLC. Market capitalization and percentage share of the global pharmaceutical market to be assumed by the merger; Views from Andrew Fenton, a pharmaceutical industry analyst with PriceWaterhouseCoopers; Combined sales of the ...
摘要: Provides information on the merger between drug companies Glaxo Wellcome and SmithKline Beecham which created Glaxo SmithKline PLC. Implications of the merger to the drug industry; Restructuring activities as a result of the merger; Plans of the merger partners. 年份: 1999 收藏...
Highlights the move of Glaxo Wellcome PLC and SmithKline Beecham PLC in merging their research-and-development budgets. Value of the deal; Objective of the deal; Plans to take the direct-to-consumer marketing approach; Advances in human genetics; Annual research budget of Glaxo SmithKline.Wall ...